Takeover Archives - CFO

A Dedicated M&A Team May Be Worth It

Mergers & Acquisitions

A Dedicated M&A Team May Be Worth It

A new academic study finds that specialized M&A staffs help acquirers identify targets that have higher synergies.

By Vincent Ryan | May 11, 2021

P&G Scraps Deal to Buy Billie Razor Startup

P&G Scraps Deal to Buy Billie Razor Startup

The termination of the proposed merger comes after regulators alleged it would cause "significant harm" to consumers.

By Matthew Heller | January 5, 2021

Cinema Chain Merger Heads for Court Fight

Cinema Chain Merger Heads for Court Fight

Cineplex accuses Cineworld of "buyer's remorse" and seeking to avoid its obligations under the merger agreement because of the COVID-19 pandemic.

By Matthew Heller | June 15, 2020

Akorn Files for Chapter 11 After Failed Takeover

Credit & Capital

Akorn Files for Chapter 11 After Failed Takeover

The generic drugmaker listed $10 billion of debt and $10 billion of assets.

By Lauren Muskett | May 21, 2020

Perry Ellis Ends Takeover Talks With Randa

Perry Ellis Ends Takeover Talks With Randa

The apparent demise of Randa's $460 million proposal clears the way for Perry Ellis to be taken private by founder George Feldenkreis.

By Matthew Heller | August 14, 2018

Smurfit Spurns International Paper’s New Offer

Smurfit Spurns International Paper’s New Offer

The Irish packaging firm says the revised proposal "does not make strategic sense" and would expose shareholders to "significantly greater leverage."

By Matthew Heller | March 26, 2018

Fidelity National Buys Title Insurance Rival

Fidelity National Buys Title Insurance Rival

The $1.2 billion purchase of Stewart Information Services will strengthen Fidelity's position as the No. 1 title insurance underwriter in the U.S.

By Matthew Heller | March 19, 2018

Qualcomm Agrees to Talk With Broadcom

Qualcomm Agrees to Talk With Broadcom

The companies will meet on Wednesday even though Qualcomm has rejected its rival's improved $121 billion takeover offer as inadequate.

By Matthew Heller | February 12, 2018

CPA Accused of Illegal Trades on Drug Firm News

Risk & Compliance

CPA Accused of Illegal Trades on Drug Firm News

The former accountant at Celator Pharmaceuticals allegedly passed on tips about market-moving announcements by the company to friends.

By Matthew Heller | September 1, 2017

Bass Pro Shops Reels in Cabela’s for $5.5B

Bass Pro Shops Reels in Cabela’s for $5.5B

The merger between two of the largest outdoor gear retailers would add Cabela's 85 stores and "loyal following" to Bass Pro's system.

By Matthew Heller | October 3, 2016

Pier 1 Counters Hedge Fund With Poison Pill

Mergers & Acquisitions

Pier 1 Counters Hedge Fund With Poison Pill

The retailer follows Alden Global's purchase of a 9.5% stake with a plan to protect shareholders from “coercive or unfair” tactics.

By Matthew Heller | September 28, 2016

Bayer Clinches Monsanto Takeover for $66B

Bayer Clinches Monsanto Takeover for $66B

The deal continues the wave of consolidation in agribusiness, pairing Bayer's strength in crop chemicals with Monsanto's portfolio of seed products.

By Matthew Heller | September 14, 2016

Pfizer Makes Cancer Play With Medivation Deal

Pfizer Makes Cancer Play With Medivation Deal

The $14 billion acquisition would add the best-selling prostate cancer drug Xtandi to Pfizer's growing oncology portfolio.

By Matthew Heller | August 22, 2016

Mondelez Offer Not Sweet Enough for Hershey

Mondelez Offer Not Sweet Enough for Hershey

The $22.8 billion proposal would create the world's largest candy maker but the Hershey Trust may stand in the way of any suitor.

By Matthew Heller | June 30, 2016

Williams Cos. Fights for Energy Transfer Merger

Williams Cos. Fights for Energy Transfer Merger

Investors backed Williams' board, which is appealing a judge's ruling that Energy Transfer can walk away from the deal.

By Matthew Heller | June 28, 2016